xA0; Melanocortin Receptor System. PL8177 is a cyclic peptide comprised of seven amino acids. There are no reported MC1r agonist drugs in clinical trials for non-infectious uveitis. xA0; PL9643 for Anti-Inflammatory Ocular Indications. The presumptive term of the issued patents and pending patent applications is until 2030. Patent litigation is costly and time consuming. xA0; 7 Proprietary Information. Similar restrictive requirements also apply in other countries. These phases may sometimes overlap or be combined. In addition, recent health care reform legislation has strengthened these laws. Flibanserin, sold under the trade name Addyi, is similarly classified as a Tier 3 drug. The reference to our website is an inactive textual reference only. Engaging a third party to perform these services could impede sales of Vyleesi. We may not be able to enter into suitable agreements on acceptable terms, if at all. Cyberattacks are increasing in their frequency, sophistication and intensity. Congress may consider other legislation to repeal or replace elements of the ACA. xA0; We are incorporated in Delaware.